Chemical companies standpoints about certifiability of 3D resins

Photopolymer 3D resins can be used to manufacture parts for demanding and, in some cases, regulated applications. However, the regulatory status and safety of the finished product (a medical device or a food-contact article) are not determined by the liquid resin alone.

For this reason, many large chemical companies supplying photopolymer materials (e.g., BASF, Mitsubishi, Covestro / DSM-Somos and others) typically do not position the liquid resin itself as a “certified finished medical device”, because device-level conformity depends on manufacturing variables outside the resin supplier’s direct control.

Core principle: the finished product must be validated and controlled

Medical device manufacturers (including point-of-care manufacturers when they act as manufacturers) are responsible for the quality, safety, performance and regulatory conformity of the finished medical device.

Raw material suppliers (including 3D resin manufacturers) can support with materials, specifications, quality control and Instructions for Use (IFUs), but they cannot replace the manufacturer’s responsibility to validate and control the complete workflow for the intended use.

Medical devices vs food-contact packaging (not the same framework)

Medical devices

Medical device conformity is assessed at the level of the finished device and its intended use, including evidence that the complete manufacturing process consistently produces safe and effective products.

Food-contact and pharma packaging

Food-contact and pharma packaging typically rely on compliance with applicable food-contact regulations (e.g., migration limits, GMP, suitable declaration of compliance), again determined by the final article and its validated process rather than the liquid raw material alone.

What must be qualified in a photopolymer workflow

For any regulated or safety-critical application, manufacturers must qualify and control the full manufacturing chain, including:

The chosen resin system: formulation/version, lot control, storage and handling.
The chosen printer: wavelength, optical uniformity, temperature behavior, and stability.
Printing parameters: layer thickness, exposure strategy, orientation, supports and energy dosage.
Post-processing: washing/cleaning method, drying, post-curing unit, time/temperature, and any final finishing steps.
Quality controls: dimensional checks, mechanical verification where relevant, and process traceability.

Why “resin-level certification” cannot guarantee finished-part safety

1) Light power decay and variability must be managed

Printers and post-curing units can experience light output drift/decay over time. Without prevention and calibration logic, the degree of cure can vary, affecting mechanical properties and safety.

2) Extractables and leachables must be assessed and controlled

Residual monomers, byproducts and other species may remain in printed parts depending on curing and cleaning effectiveness. For safety-critical applications, these must be evaluated and controlled to acceptable levels under the manufacturer’s validated workflow (not assumed to be “zero” by default).

3) Post-processing effectiveness must be proven (not assumed)

Manufacturing protocols must demonstrate that cleaning and post-curing achieve the required conversion and cleanliness for the intended use. Simple, non-validated guidance (e.g., “rinse with IPA”) is often insufficient for safety-critical or regulated uses without workflow qualification and verification.

Practical conclusion

In photopolymer additive manufacturing, safety and conformity are workflow outcomes. The liquid resin is a critical input, but the final result depends on the complete system: resin + printer + parameters + post-processing + quality controls.